Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money faster than the Fed. But here's what the bulls aren't

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy called "most favored nation."